These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 15638068)
1. Attenuation of neuroleptic-induced extrapyramidal side effects by Kava special extract WS 1490. Boerner RJ; Klement S Wien Med Wochenschr; 2004 Nov; 154(21-22):508-10. PubMed ID: 15638068 [TBL] [Abstract][Full Text] [Related]
2. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
4. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321 [TBL] [Abstract][Full Text] [Related]
5. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia. Andrew HG Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668 [TBL] [Abstract][Full Text] [Related]
6. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms. Bezchlibnyk-Butler KZ; Remington GJ Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605 [TBL] [Abstract][Full Text] [Related]
7. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment. Schwartz M; Weller B; Erdreich M; Sharf B J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962 [No Abstract] [Full Text] [Related]
8. Treatment of extrapyramidal side effects with terguride. Filip V; Marsálek M; Hálková E; Karen P Psychiatry Res; 1992 Jan; 41(1):9-16. PubMed ID: 1348584 [TBL] [Abstract][Full Text] [Related]
9. Buspirone in the treatment of tardive dyskinesia. Moss LE; Neppe VM; Drevets WC J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622 [TBL] [Abstract][Full Text] [Related]
10. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310 [TBL] [Abstract][Full Text] [Related]
11. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases. Friedman JH Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739 [TBL] [Abstract][Full Text] [Related]
12. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms. Wilbur R; Kulik FA Prog Neuropsychopharmacol; 1980; 4(6):627-32. PubMed ID: 6111820 [No Abstract] [Full Text] [Related]
13. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. Barnes TR; McPhillips MA Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971 [TBL] [Abstract][Full Text] [Related]
14. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects. Schlösser R; Schlegel S; Hiemke C; Nickel O; Bockisch A; Rao ML; Hahn K Psychiatry Res; 1997 Sep; 75(2):103-14. PubMed ID: 9351492 [TBL] [Abstract][Full Text] [Related]
15. Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology. Gervin M; Browne S; Garavan J; Roe M; Larkin C; O'Callaghan E Eur Psychiatry; 1999 Nov; 14(7):405-9. PubMed ID: 10683626 [TBL] [Abstract][Full Text] [Related]